Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
NovaBay Pharmaceuticals, Inc. develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health. The company also provides wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. It sells its products through the company's web stores, third-party online retailers and distribution partners. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California. more
Time Frame | NBY | Sector | S&P500 |
---|---|---|---|
1-Week Return | 2.9% | -1.85% | -0.15% |
1-Month Return | -16.52% | -3.48% | 0.71% |
3-Month Return | 29.08% | -7.47% | 9.92% |
6-Month Return | -79.13% | -1.95% | 12.57% |
1-Year Return | -94.04% | 8.39% | 30.57% |
3-Year Return | -99.91% | 7.07% | 28.07% |
5-Year Return | -99.92% | 44.2% | 92.45% |
10-Year Return | -100% | 106.89% | 197.42% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 6.60M | 9.93M | 8.42M | 14.40M | 14.73M | [{"date":"2019-12-31","value":44.81,"profit":true},{"date":"2020-12-31","value":67.46,"profit":true},{"date":"2021-12-31","value":57.18,"profit":true},{"date":"2022-12-31","value":97.81,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 1.74M | 3.97M | 2.78M | 6.62M | 6.83M | [{"date":"2019-12-31","value":25.44,"profit":true},{"date":"2020-12-31","value":58.12,"profit":true},{"date":"2021-12-31","value":40.64,"profit":true},{"date":"2022-12-31","value":96.96,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 4.86M | 5.96M | 5.64M | 7.78M | 7.89M | [{"date":"2019-12-31","value":61.57,"profit":true},{"date":"2020-12-31","value":75.54,"profit":true},{"date":"2021-12-31","value":71.5,"profit":true},{"date":"2022-12-31","value":98.56,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 73.66% | 60.04% | 67.03% | 54.02% | 53.61% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":81.5,"profit":true},{"date":"2021-12-31","value":91,"profit":true},{"date":"2022-12-31","value":73.33,"profit":true},{"date":"2023-12-31","value":72.78,"profit":true}] |
Operating Expenses | 14.26M | 12.39M | 14.51M | 15.46M | 12.90M | [{"date":"2019-12-31","value":92.24,"profit":true},{"date":"2020-12-31","value":80.14,"profit":true},{"date":"2021-12-31","value":93.83,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":83.42,"profit":true}] |
Operating Income | (9.40M) | (6.43M) | (8.86M) | (7.68M) | (5.00M) | [{"date":"2019-12-31","value":-940000000,"profit":false},{"date":"2020-12-31","value":-642600000,"profit":false},{"date":"2021-12-31","value":-886200000,"profit":false},{"date":"2022-12-31","value":-768000000,"profit":false},{"date":"2023-12-31","value":-500300000,"profit":false}] |
Total Non-Operating Income/Expense | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Pre-Tax Income | (9.65M) | (11.03M) | (5.82M) | (10.61M) | (9.64M) | [{"date":"2019-12-31","value":-965200000,"profit":false},{"date":"2020-12-31","value":-1103400000,"profit":false},{"date":"2021-12-31","value":-582400000,"profit":false},{"date":"2022-12-31","value":-1060800000,"profit":false},{"date":"2023-12-31","value":-964000000,"profit":false}] |
Income Taxes | 6.00K | 5.00K | (4.62M) | (3.81M) | 35.10K | [{"date":"2019-12-31","value":17.09,"profit":true},{"date":"2020-12-31","value":14.24,"profit":true},{"date":"2021-12-31","value":-13146.28,"profit":false},{"date":"2022-12-31","value":-10850.31,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income From Continuous Operations | (9.66M) | (11.04M) | (5.82M) | (10.61M) | (13.74M) | [{"date":"2019-12-31","value":-965800000,"profit":false},{"date":"2020-12-31","value":-1103900000,"profit":false},{"date":"2021-12-31","value":-582400000,"profit":false},{"date":"2022-12-31","value":-1060800000,"profit":false},{"date":"2023-12-31","value":-1373800000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (10.49M) | (11.04M) | (6.56M) | (16.27M) | (9.64M) | [{"date":"2019-12-31","value":-1048700000,"profit":false},{"date":"2020-12-31","value":-1103900000,"profit":false},{"date":"2021-12-31","value":-655900000,"profit":false},{"date":"2022-12-31","value":-1626500000,"profit":false},{"date":"2023-12-31","value":-964000000,"profit":false}] |
EPS (Diluted) | (16.80) | (11.55) | (5.25) | (7.43) | (3.19) | [{"date":"2019-12-31","value":-1680,"profit":false},{"date":"2020-12-31","value":-1155,"profit":false},{"date":"2021-12-31","value":-525,"profit":false},{"date":"2022-12-31","value":-743,"profit":false},{"date":"2023-12-31","value":-319,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
NBY | |
---|---|
Cash Ratio | 0.39 |
Current Ratio | 1.15 |
Quick Ratio | 0.91 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
NBY | |
---|---|
ROA (LTM) | -38.67% |
ROE (LTM) | -263.83% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
NBY | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.72 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.28 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
NBY | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.22 |
P/B | 2.71 |
Price/FCF | NM |
EV/R | 0.24 |
EV/Ebitda | NM |
PEG | NM |
NovaBay Pharmaceuticals Inc (NBY) share price today is $0.532
Yes, Indians can buy shares of NovaBay Pharmaceuticals Inc (NBY) on Vested. To buy NovaBay Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NBY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of NovaBay Pharmaceuticals Inc (NBY) via the Vested app. You can start investing in NovaBay Pharmaceuticals Inc (NBY) with a minimum investment of $1.
You can invest in shares of NovaBay Pharmaceuticals Inc (NBY) via Vested in three simple steps:
The 52-week high price of NovaBay Pharmaceuticals Inc (NBY) is $10.15. The 52-week low price of NovaBay Pharmaceuticals Inc (NBY) is $0.36.
The price-to-earnings (P/E) ratio of NovaBay Pharmaceuticals Inc (NBY) is
The price-to-book (P/B) ratio of NovaBay Pharmaceuticals Inc (NBY) is 2.71
The dividend yield of NovaBay Pharmaceuticals Inc (NBY) is 0.00%
The market capitalization of NovaBay Pharmaceuticals Inc (NBY) is $2.89M
The stock symbol (or ticker) of NovaBay Pharmaceuticals Inc is NBY